• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON SARL GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON SARL GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Catalog Number PFRT01
Device Problems Migration or Expulsion of Device (1395); Appropriate Term/Code Not Available (3191)
Patient Problems Erosion (1750); Incontinence (1928); Pain (1994); No Code Available (3191)
Event Type  Injury  
Manufacturer Narrative
(b)(4).In addition, a review of the batch manufacturing records was conducted and the batch met all finished goods release criteria.To date the device has not been returned.If the device or further details are received at a later date a supplemental medwatch will be sent.(b)(4).Total number of events ¿ 200.Gynecare prolift +m anterior pelvic floor repair system ¿ 14.Gynecare prolift +m pelvic floor repair system ¿ 3.Gynecare prolift +m posterior pelvic floor repair system ¿ 8.Gynecare prolift +m total pelvic floor repair system ¿ 13.Gynecare prolift anterior pelvic floor repair system ¿ 34.Gynecare prolift pelvic floor repair system ¿ 41.Gynecare prolift posterior pelvic floor repair system ¿ 20.Gynecare prolift total pelvic floor repair system ¿ 48.Gynecare prosima pelvic floor repair system ¿ 20.
 
Event Description
It was reported by an attorney that the patient underwent a gynecological surgical procedure on (b)(6) 2007 concurrently with total vaginal hysterectomy, bilateral salpingo-oophorectomy, mccall¿s culdoplasty and uterosacral vault suspension and the mesh was implanted due to uterovaginal prolapse, cystocele, rectocele and urinary incontinence.Following the procedure, the patient experienced dyspareunia and urinary incontinence.It was reported that the patient underwent a mesh removal on (b)(6) 2015.No further information is available.
 
Manufacturer Narrative
(b)(4).
 
Manufacturer Narrative
Date sent to the fda: 04/20/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to the fda: 06/28/2017.Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Patient codes: (b)(4) device codes: (b)(4) ethicon mdr summary reporting exemption (b)(4) reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4) reporting period (b)(6) 2016 through (b)(6) 2016 supplemental 06 - attachment: [(b)(6) 2016 otp supplemental 06.Xlsx].
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Ethicon mdr summary reporting exemption (b)(4).Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: (b)(4) 2018.Ethicon mdr summary reporting exemption e2013037 reporting period (b)(4) 2016 through (b)(4) 2016.
 
Manufacturer Narrative
Date sent to fda: 12/27/2018.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 02/12/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 04/24/2019.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Manufacturer Narrative
Date sent to fda: 04/19/2021.Ethicon mdr summary reporting exemption e2013037.Reporting period october 1, 2016 through november 30, 2016.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GYNECARE PROLIFT TOTAL PELVIC FLOOR REPAIR SYSTEM
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON SARL
puits-godet 20
neuchatel 2000
SZ  2000
MDR Report Key6193920
MDR Text Key62959488
Report Number2210968-2016-34409
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
PMA/PMN Number
K013718
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 09/06/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2010
Device Catalogue NumberPFRT01
Device Lot Number3010361
Was Device Available for Evaluation? Yes
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 09/02/2016
Initial Date FDA Received12/21/2016
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Not provided
09/02/2016
09/02/2016
09/02/2016
09/02/2016
09/02/2016
09/02/2016
09/02/2016
10/25/2018
12/27/2018
02/12/2019
04/24/2019
04/19/2021
Supplement Dates FDA Received02/24/2017
04/20/2017
06/28/2017
08/29/2017
10/24/2017
12/27/2017
02/22/2018
04/12/2018
06/22/2018
08/16/2018
10/26/2018
12/27/2018
02/12/2019
04/24/2019
04/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age62 YR
-
-